ClinicalTrials.gg
Not yet recruitingNCT07724665Updated Jul 24, 2026

Effects Of Scapulothoracic Intervention With Or Without Neural Mobilization In Patients With Cervico-Brachialgia

An interventional study of Scapulothoracic intervention with Neural Mobilization and Neural Mobilization in Cervico Brachialgia, sponsored by Riphah International University. Not yet recruiting. Open to participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 209 studies in Pain by Riphah International University — 86 open to participants now, 90 under way, none of them phase 3. Pain · Riphah International University.

Planned enrollment
54th of 207
44 · median 38
Started
2026
with 22 others
No phase
207 of 209
86 open now
Primary completion
2026-11
later than 81 of 89 live
Registered
198th of 209
by date

Among the 209 studies in Pain by Riphah International University, this one is the 54th largest by planned enrollment of the 207 interventional ones that give a count, is one of 23 that started in 2026, is one of 207 with no phase, reaches primary completion later than 81 of the 89 other live ones, and was the 198th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

86 of the 209 studies in Pain by Riphah International University are open now, in 1 country. Recruiting first, the newest first:

81 more — sign in →

By country, each count listing its studies:

All 86 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 30 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 209 studies in Pain by Riphah International University, or all of them as a file.
02

Study summary

Cervicobrachialgia is a common musculoskeletal condition characterized by neck pain radiating into the upper limb due to neural and musculoskeletal dysfunctions. It is often associated with pain, functional disability, and increased neural mechanosensitivity, significantly affecting daily activities and quality of life. Various physiotherapy interventions have been used to manage this condition, including neural mobilization and scapulothoracic rehabilitation. However, evidence regarding the combined effectiveness of these interventions remains limited.

Read the detailed description

The aim of the study is to determine the effects of scapulothoracic intervention with or without neural mobilization on pain, function, and neural mechanosensitivity in patients with cervicobrachialgia.

Methods: A randomized controlled trial will be conducted on 40 patients diagnosed with cervicobrachialgia. Participants will be randomly allocated into two groups, with 20 participants in each group. Group A received scapulothoracic rehabilitation combined with neural mobilization (ST+NM), while Group B received neural mobilization alone (NM). Treatment will be administered according to the study protocol over the intervention period. Outcome measures includes the Numeric Pain Rating Scale (NPRS) for pain intensity, Neck Pain Questionnaire (NPQ) for neck-related disability, PainDETECT Questionnaire (PDQ) for neuropathic pain symptoms, and Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire for upper limb function. Assessments were performed before and after the intervention. Data will be analyzed using paired sample t-tests, independent sample t-tests, Mann-Whitney U tests, and Wilcoxon Signed Rank tests with a significance level of p\<0.05.

03

Conditions studied

  • Cervico Brachialgia

Browse trials for

Keywords

  • Disability, Mobilization, Neural, Pain, Scapula
04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cervicobrachial pain
  • Females and males
  • Aged 30-50 years
  • Able to communicate and follow the instructions
  • Able to perform cervical exercises according to cervicogenic pain

Exclusion criteria

Exclusion Criteria:

  • Negative neurodynamic test
  • Neck and upper extremity surgery
  • Vertebral instability
  • Vertebral spine infection
  • Neurological disease of genetic, infection, or neuroplastic origin
  • Inflammatory or systemic disease
  • VBI symptoms
  • Rheumatoid arthritis
  • Subjects with presence of any fractures.
  • Heart/diabetic patient
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Scapulothoracic intervention with Neural Mobilization

    Group A received Scapulothoracic intervention with Neural Mobilization

    Other: Scapulothoracic intervention with Neural Mobilization

  • Active comparator
    Neural Mobilization

    Group B received Neural Mobilization alone.

    Other: Neural Mobilization

Interventions

  • OtherScapulothoracic intervention with Neural Mobilization

    Neural Mobilization: Pain-free tension 1. Scapular Mobilization: * Grades III-IV joint mobs (elevation/depression/retraction) * 3 sets × 10 reps 2. Strengthening: * Serratus punches (progress to resistance bands) * Lower trap raises (prone Y-lifts) * 3 sets × 12 reps 3. Neural Mobilization: * ULNT1 sliding technique (6 sec hold/6 sec rest)

  • OtherNeural Mobilization

    Neural Mobilization: Pain-free tension 1. Cervical Isometrics: * 4-way neck contractions (5-sec hold) * 3 sets × 10 reps 2. Postural Education: • Ergonomics training 3. Modalities: • TENS (80Hz, 100μs) or moist heat pack 4. Neural Mobilization: * ULNT1 (same as Group A)

06

What researchers measure

Primary outcomes

  1. Visual Analogue Scale (VAS)

    The VAS is a common, subjective measurement tool that is used to measure the level of pain severity using an 11-point range with zero (no pain) and ten (heaviest pain imaginable). Patients use a subjective scale to rate their pain verbally and the following scales apply to 1-3 mild, 4-6 moderate, and 7-10 severe pain.

    Time frame: upto 6 weeks

  2. Northwick Park Neck Pain Questionnaire (NPQ)

    The NPQ is a 9- questionnaire assessing neck pain disability with each question put on a scale of 0 to 4(code converted to percentage). It examines nocturnal sleep, activities during the day, and social goals. With cervicobrachialgia, it is used to measure functional restrictiveness such as neck/arm pain. Scores: 0-20 percent (light), 21-40 percent (moderate), \>40 percent (severe).

    Time frame: upto 6 weeks

Secondary outcomes

  1. PainDETECT questionnaire (PD-Q)

    It is a 9-item instrument that has 7 scored items 0-5, and 2 items of the pain pattern characteristics of neuropathic pain in cervicobrachialgia. score 0-38: \<13 (not likely neuropathic), 13-18 (indeterminate), \>=19 (probable neuropathic). It assesses the quality of pain (burning, tingling etc.), radiation patterns.

    Time frame: upto 6 weeks

  2. Disability of Arm, Shoulder and Hand (DASH)

    The DASH assesses upper limb disability and is a 30 item questionnaire scaled 1-5. The total point (0-100) is counted: \[(the sum of the responses/n) -1\] x 25. The higher the score and the more they are disabled. The course is minimal clinically significant difference, 10 points. In case of cervicobrachialgia, it examines the impairment of arm functioning.

    Time frame: upto 6 weeks

  3. FABF Questionnaire (FABQ)

    FABQ contains 16 items consisting of two subscales namely, physical activity (4 items, 0-24) and work (7 items, 0-42). The more the score, the higher fear-avoidance. In cervicobrachialgia, scores above 14 (work) or 12 (physical activity), predict an unsatisfactory recovery.

    Time frame: upto 6 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Wagner FM. [Somatic dysfunction of the cervical spine and its complex clinical picture : The fundamentals of diagnostics of cervicobrachialgia and cervicocephalic syndrome through manual medicine]. Orthopade. 2022 Apr;51(4):263-273. doi: 10.1007/s00132-022-04228-7. Epub 2022 Mar 3. German. PubMed 35238967 ↗
  • Sanchez AC, Requena JBS, Pantaleaon LAL, Esqueda ATI, Raidi VMV, Gallardo IR, et al. # 36401 Post-traumatic compressive C6 cervicobrachialgia, not all that glitters is gold. BMJ Publishing Group Ltd; 2023.
  • Kerimova EK, Isaikin AI, Romanova AS, Bashlachev MG, Mouki K. Cervicalgia and cervicobrachialgia in periarticular cyst at the cervical level. Case report. Consilium Medicum. 2025;27(02):94-8.
  • Thomson S, Ainsworth G, Selvanathan S, Brown S, Croft J, Kelly R, Mujica-Mota R, Rousseau N, Higham R, Stocken D. Clinical and cost-effectiveness of PCF versus ACD in the treatment of cervical brachialgia (FORVAD trial). Br J Neurosurg. 2024 Feb;38(1):141-148. doi: 10.1080/02688697.2023.2267119. Epub 2024 Jan 27. PubMed 37807634 ↗
  • Fujastawan IGV. Management of Physiotherapy in Case of Brachialgia Due to Cervical Spondyloarthrosis. Science Midwifery. 2022;10(2):755-8.
  • Rani A, Chopra J, Singh RR, Bajpai PK. Prevalence of various anomalies of costal element at cervico-thoracic junction in and around lucknow region of uttarpradesh: A radiological study. Biomed Res. 2021;32(1):7-14.
  • AHMED AA, SHABAN M. Conservative Treatment of Cervical Discs without Myelopathy: A Three Years Follow-up. The Medical Journal of Cairo University. 2023;91(03):403-7.
  • Thomson S, Ainsworth G, Selvanathan S, Kelly R, Collier H, Mujica-Mota R, Talbot R, Brown ST, Croft J, Rousseau N, Higham R, Al-Tamimi Y, Buxton N, Carleton-Bland N, Gledhill M, Halstead V, Hutchinson P, Meacock J, Mukerji N, Pal D, Vargas-Palacios A, Prasad A, Wilby M, Stocken D. Posterior cervical foraminotomy versus anterior cervical discectomy for Cervical Brachialgia: the FORVAD RCT. Health Technol Assess. 2023 Oct;27(21):1-228. doi: 10.3310/OTOH7720. PubMed 37929307 ↗
  • Korman DV, Yushmanov IG. The influence of osteopathic correction to the level of stress in patients with cervicobrachialgia. Российский остеопатический. 2020:56.
  • Ilić J, Kostić A, Ilić M, Nikolov V, Stojanović N, Todorović S. Cervicobrachial syndrome: Prevalence and clinical correlation with coronavirus 2019 disease among hospitalized patients. Acta Medica Medianae. 2024;63(3).

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Nov 2026, 4 months later.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 4 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2026
First posted
Jul 24, 2026
StartEst.
Jul 2026
Primary completionEst.
Nov 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Jul 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07724665
Responsible party
Sponsor
First posted
Jul 24, 2026
Start date
Jul 2026 (estimated)
Primary completion
Nov 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Jul 24, 2026

Study contacts

Sumrod Akram
Contact
samrood.akram@riphah.edu.pk
03324806143
Ramish Safraz
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion